ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylethylamine → (2S,4R)-1-(2-(1H-1,2,3-triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-N-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide

HRID 1630299
ノート
印刷プレビュー

反応式

HRID 1630299 の反応式
[F:1][C:2]1[CH:23]=[CH:22][C:5]([O:6][C:7]2[CH:12]=[CH:11][C:10]([NH:13][C:14]([C@@H:16]3[CH2:20][C@@H:19](O)[CH2:18][NH:17]3)=[O:15])=[CH:9][CH:8]=2)=[CH:4][CH:3]=1.[N:24]1([CH2:29][C:30]([OH:32])=O)[CH:28]=[CH:27][N:26]=[N:25]1.CCN([CH:39]([CH3:41])C)C(C)C.CN(C(ON1N=N[C:52]2[CH:53]=[CH:54][CH:55]=N[C:51]1=2)=[N+](C)C)C.[F:59][P-](F)(F)(F)(F)F>CN(C=O)C>[N:24]1([CH2:29][C:30]([N:17]2[CH2:18][C@H:19]([CH2:51][C:52]3[CH:41]=[CH:39][C:55]([F:59])=[CH:54][CH:53]=3)[CH2:20][C@H:16]2[C:14]([NH:13][C:10]2[CH:11]=[CH:12][C:7]([O:6][C:5]3[CH:22]=[CH:23][C:2]([F:1])=[CH:3][CH:4]=3)=[CH:8][CH:9]=2)=[O:15])=[O:32])[CH:28]=[CH:27][N:26]=[N:25]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 190184992-(1H-1,2,3-triazol-1-yl)acetic acidHCID 56954162(2S,4R)-N-(4-(4-fluorophenoxy)phenyl)-4-hydroxypyrrolidine-2-carboxamide

生成物 1

HCID 45377018
(2S,4R)-1-(2-(1H-1,2,3-triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-N-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide
収率 23%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

A flask was charged with crude (2S,4R)—N-(4-(4-fluorophenoxy)phenyl)-4-hydroxypyrrolidine-2-carboxamide (0.452 g), 2-(1H-1,2,3-triazol-1-yl)acetic acid (169 g, 1.33 mmol), DIEA (3.0 mL, 17 mmol), HATU (0.506 g, 1.33 mmol) and DMF (10 mL). The reaction mixture was stirred at ambient temperature for 1 hour and then quenched with saturated sodium bicarbonate (aq., 10 mL). The mixture was extracted with ethyl acetate (20 mL) and the extract was washed with deionized water (10 mL) and then brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated. Product was purified from the residue was purified by reverse phase HPLC to provide Compound 75, (2S,4R)-1-(2-(1H-1,2,3-triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-N-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (0.115 g, 0.222 mmol, 23% yield). 1H-NMR (400 MHz, CDCl3): δ 8.95 (s, 1H), 7.77 (d, 2H), 7.43 (d, 2H), 7.16 (dd, 2H), 7.04-6.98 (m, 4H), 6.94-6.89 (m, 3H), 5.28 (d, 1H), 5.14 (d, 1H), 4.80 (d, 1H), 4.12 (dd, 1H), 3.68 (dd, 1H), 3.26 (t, 1H), 3.02-2.92 (m, 1H), 2.89 (dd, 1H), 2.71-2.59 (m, 1H), 2.74-2.65 (m, 1H). MS (EI) for C28H25F2N5O3 found 518.2 (MH+).

後処理

  1. customquenched with saturated sodium bicarbonate (aq., 10 mL)
  2. extractionThe mixture was extracted with ethyl acetate (20 mL)
  3. washthe extract was washed with deionized water (10 mL)
  4. dry with materialbrine (10 mL), dried over anhydrous sodium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customProduct was purified from the residue
  8. customwas purified by reverse phase HPLC

出典と根拠

ORDレコード
ord-8e6f2d701a354f5aa8ba4c658dc36a62
出典データセット
uspto-grants-2014_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08791102B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート